Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 9


Results: 8
    1
    2
    3
    4
    5
    6

    Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2− Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.

    Published in:
    Clinical Drug Investigation, 2023, v. 43, n. 9, p. 699, doi. 10.1007/s40261-023-01294-3
    By:
    • Fein, Luis;
    • Lazaretti, Nicolas;
    • Chuken, Yamil López;
    • Benfield, J. Rogelio González Ramírez;
    • Mano, Max S.;
    • Lobaton, Jose;
    • Korbenfeld, Ernesto;
    • Damian, Fernanda;
    • Lu, Dongrui R.;
    • Mori, Ave;
    • Patyna, Shem J.;
    • Franco, Sandra
    Publication type:
    Article
    7

    Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence.

    Published in:
    Clinical Drug Investigation, 2023, v. 43, n. 9, p. 691, doi. 10.1007/s40261-023-01291-6
    By:
    • de Pinho, Inês Soares;
    • Luz, Paulo;
    • Alves, Lucy;
    • Lopes-Brás, Raquel;
    • Patel, Vanessa;
    • Esperança-Martins, Miguel;
    • Gonçalves, Lisa;
    • Freitas, Ritas;
    • Simão, Diana;
    • Galnares, Maria Roldán;
    • Fernandes, Isabel;
    • Criado, Silvia Artacho;
    • Casado, Salvador Gamez;
    • Cañada, Jose Baena;
    • Vega, Isabel M. Saffie;
    • Costa, João G.;
    • Fernandes, Ana S.;
    • de Sousa, Rita Teixeira;
    • Costa, Luís
    Publication type:
    Article
    8